Advertisement

Topics

Acne Vulgaris Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $2000

21:41 EDT 31 Jul 2017 | BioPortfolio Reports

DelveInsight's, Acne Vulgaris Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Acne Vulgaris. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Acne Vulgaris. This report provides information on the therapeutic development for Acne Vulgaris, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, preclinical as well as discovery products. The report further contains details on dormant products and discontinued products. Therapeutic assessment of all the active products by route of administration and molecule type is also covered in this report.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Allergan Pharma
Almirall
AndroScience Corporation
AntibioTx
AntiCancer
AOBiome
Arkin Dermatology
Basilea Pharmaceutica
Biomar Microbial Technologies
BioPharmX
Blueberry Therapeutics
Botanix Pharmaceuticals Ltd.
Braintree Laboratories
Brickell Biotech Inc.
Cassiopea SpA

Cell Medica Ltd.
Cellceutix
Celtaxsys Inc.
Cutanea Life Sciences
Dermata Therapeutics LLC
DermaXon
Dermira Inc.
Diffusion Pharmaceuticals Inc.
Elorac
Foamix Pharmaceuticals Ltd.
Galderma S.A.
GlaxoSmtihKline
Helix BioMedix
HSRx Group
LEO Pharma
Luzitin
Mimetica Pty Limited
Novan Inc.
Novartis
Paratek Pharmaceuticals
Pfizer
Photocure ASA
Promius Pharma LLC

SolGel Technologies
Thesan Pharmaceuticals Inc.
Valeant Pharmaceuticals
Vyome Biosciences
XBiotech Inc.
Xenon Pharmaceuticals Inc.
XOMA Corporation



Acne Vulgaris Pipeline Drugs
Acne Vulgaris Pipeline Assessment
Acne Vulgaris Pipeline Analysis
Acne Vulgaris Drugs under Development
Acne Vulgaris Discovery drugs
Acne Vulgaris Preclinical drugs
Acne Vulgaris Phase I drugs
Acne Vulgaris Phase II drugs
Acne Vulgaris Phase III Pipeline Drugs Assessment
Acne Vulgaris Preregistration drugs
Acne Vulgaris Molecules in pipeline

Original Article: Acne Vulgaris Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $2000

NEXT ARTICLE

More From BioPortfolio on "Acne Vulgaris Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $2000"

Quick Search
Advertisement
 

Relevant Topics

Acne
Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...